通过新型免疫抑制剂FTY720治疗实现同种异体移植大鼠和犬的长期移植物接受。 - Suppr

Suppr

超能文献

Long-term graft acceptance in allografted rats and dogs by treatment with a novel immunosuppressant, FTY720.

作者信息

Suzuki S, Enosawa S, Kakefuda T, Amemiya H, Hoshino Y, Chiba K

机构信息

Department of Experimental Surgery and Bioengineering, National Children's Medical Research Center, Tokyo, Japan.

出版信息

Transplant Proc. 1996 Jun;28(3):1375-6.

PMID:8658701

Abstract

摘要

相似文献

Long-term graft acceptance in allografted rats and dogs by treatment with a novel immunosuppressant, FTY720.

Transplant Proc. 1996 Jun;28(3):1375-6.

FTY720, a novel immunosuppressant possessing unique mechanisms. II. Long-term graft survival induction in rat heterotopic cardiac allografts and synergistic effect in combination with cyclosporine A.

Transplant Proc. 1996 Apr;28(2):1060-1.

Effect of a novel immunosuppressant, FTY720, on heart and liver transplantations in rats.

Transplant Proc. 1999 Feb-Mar;31(1-2):1178-9. doi: 10.1016/s0041-1345(98)01953-8.

FTY720, a novel immunosuppressant possessing unique mechanisms. I. Prolongation of skin allograft survival and synergistic effect in combination with cyclosporine in rats.

Transplant Proc. 1996 Apr;28(2):1056-9.

FTY720, a novel immunosuppressant possessing unique mechanisms. III. Synergistic prolongation of canine renal allograft survival in combination with cyclosporine A.

Transplant Proc. 1996 Apr;28(2):1062-3.

KRP-203, a novel synthetic immunosuppressant, prolongs graft survival and attenuates chronic rejection in rat skin and heart allografts.

Circulation. 2005 Jan 18;111(2):222-9. doi: 10.1161/01.CIR.0000152101.41037.AB. Epub 2005 Jan 10.

Treatment of chronic allograft nephropathy at late stages using everolimus or FTY720 in combination with cyclosporine.

Transplant Proc. 2008 Dec;40(10):3731-6. doi: 10.1016/j.transproceed.2008.06.114.

FTY720, a novel immunosuppressant, shows a synergistic effect in combination with FK 506 in rat allograft models.

Transplant Proc. 1999 Feb-Mar;31(1-2):1224-6. doi: 10.1016/s0041-1345(98)01973-3.

FTY720, a new immunosuppressant, as rescue therapy in mouse cardiac transplantation.

Acta Pharmacol Sin. 2003 Sep;24(9):847-52.

A new immunosuppressant, FTY720, in canine kidney transplantation: effect of single-drug, induction and combination treatments.

Transpl Int. 2004 Nov;17(10):574-84. doi: 10.1007/s00147-004-0767-7. Epub 2004 Nov 5.

引用本文的文献

Low Serum Levels of (Dihydro-)Ceramides Reflect Liver Graft Dysfunction in a Real-World Cohort of Patients Post Liver Transplantation.

Int J Mol Sci. 2018 Mar 26;19(4):991. doi: 10.3390/ijms19040991.

FTY720 increases CD74 expression and sensitizes mantle cell lymphoma cells to milatuzumab-mediated cell death.

Blood. 2011 Dec 22;118(26):6893-903. doi: 10.1182/blood-2011-06-363879. Epub 2011 Oct 31.

FTY720 shows promising in vitro and in vivo preclinical activity by downmodulating Cyclin D1 and phospho-Akt in mantle cell lymphoma.

Clin Cancer Res. 2010 Jun 15;16(12):3182-92. doi: 10.1158/1078-0432.CCR-09-2484. Epub 2010 May 11.

Pharmacological manipulation of the akt signaling pathway regulates myxoma virus replication and tropism in human cancer cells.

J Virol. 2010 Apr;84(7):3287-302. doi: 10.1128/JVI.02020-09. Epub 2010 Jan 27.

FTY720 demonstrates promising preclinical activity for chronic lymphocytic leukemia and lymphoblastic leukemia/lymphoma.

Blood. 2008 Jan 1;111(1):275-84. doi: 10.1182/blood-2006-10-053884. Epub 2007 Aug 29.

Induction of lymphocyte apoptosis in rat liver allograft with ongoing rejection by FTY720.

Clin Exp Immunol. 2001 Feb;123(2):331-9. doi: 10.1046/j.1365-2249.2001.01434.x.

FTY720, a novel immunosuppressant, induces sequestration of circulating mature lymphocytes by acceleration of lymphocyte homing in rats, III. Increase in frequency of CD62L-positive T cells in Peyer's patches by FTY720-induced lymphocyte homing.

Immunology. 1998 Dec;95(4):591-4. doi: 10.1046/j.1365-2567.1998.00639.x.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验